Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001531824 | SCV000512999 | likely benign | not provided | 2018-05-02 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000951891 | SCV001098342 | likely benign | Marfan syndrome; Familial thoracic aortic aneurysm and aortic dissection | 2025-01-20 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001187600 | SCV001354449 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2019-06-01 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001531824 | SCV001747118 | likely benign | not provided | 2021-06-01 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002502472 | SCV002808349 | likely benign | Ectopia lentis 1, isolated, autosomal dominant; Marfan syndrome; MASS syndrome; Stiff skin syndrome; Weill-Marchesani syndrome 2, dominant; Acromicric dysplasia; Geleophysic dysplasia 2; Progeroid and marfanoid aspect-lipodystrophy syndrome | 2022-05-19 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV003995958 | SCV004814668 | likely benign | Marfan syndrome | 2023-11-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001187600 | SCV005032592 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2024-02-22 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |